Zobrazeno 1 - 10
of 489
pro vyhledávání: '"Govind Babu"'
Autor:
Purvish Parikh, Govind Babu, Randeep Singh, Vamshi Krishna, Amit Bhatt, Indu Bansal, Senthil Rajappa, Tarini Prasad Sahoo, Shyam Aggarwal, Ajay Bapna, Ghanshyam Biswas, SP Somashekhar, Jyoti Bajpai, Vashishtha Maniar, Sharad Desai, T Raja, Goura Kishor Rath
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Precise prognostication is the key to optimum and effective treatment planning for early-stage hormone receptor (HR) positive, HER2/neu negative breast cancer patients. Differences in the breast cancer incidence and tumor anatomic
Externí odkaz:
https://doaj.org/article/bdbbc72b6fdc4fdf90d0d1d7652fbbf3
Autor:
Mallikarjuna Siraganahalli Eshwaraiah, Aparna Gunda, Govind Babu Kanakasetty, Manjiri M. Bakre
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13342-13351 (2023)
Abstract Background Assessment of Ki67 by immunohistochemistry (IHC) has limited utility in clinical practice owing to analytical validity issues. According to International Ki67 Working Group (IKWG) guidelines, treatment should be guided by a progno
Externí odkaz:
https://doaj.org/article/1f006e3f91d44800ba0e831c04a2685c
Autor:
Purvish M. Parikh, Gouri Shankar Bhattacharyya, Ghanshyam Biswas, Arvind Krishnamurty, Dinesh Doval, Anil Heroor, Sanjay Sharma, Ramakant Deshpande, Harit Chaturvedi, S. P. Somashekhar, Govind Babu, G. Krishna Reddy, Diptendra Sarkar, Chirag Desai, Hemant Malhotra, Nitesh Rohagi, Ajay Bapna, S. S. Alurkar, Prasad Krishna, S. V.S. Deo, Anurag Shrivastava, Prakash Chitalkar, Saroj Kumar Majumdar, Devanhalli Vijay, Aniket Thoke, K. S. Udupa, Jyoti Bajpai, G. K. Rath, Palanki Satya Dattatreya, Shailesh Bondarde, Shekhar Patil
Publikováno v:
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 213-219 (2021)
Breast cancer is a public health challenge globally as well as in India. Improving outcome and cure requires appropriate biomarker testing to assign risk and plan treatment. Because it is documented that significant ethnic and geographical variations
Externí odkaz:
https://doaj.org/article/d5d88f7cebe44f83bae006ee87b01706
Autor:
Supriya J. Chopra, Ashwathy Mathew, Amita Maheshwari, Neerja Bhatla, Shalini Singh, Bhawana Rai, Shylasree T. Surappa, Jaya Ghosh, Dayanand Sharma, Jaydip Bhaumik, Manash Biswas, Kedar Deodhar, Palak Popat, Sushil Giri, Umesh Mahantshetty, Hemant Tongaonkar, Ramesh Billimaga, Reena Engineer, Surbhi Grover, Abraham Pedicayil, Jyoti Bajpai, Bharat Rekhi, Aruna Alihari, Govind Babu, Rajkumar Thangrajan, Santosh Menon, Sneha Shah, Sidhanna Palled, Yogesh Kulkarni, Seema Gulia, Lavanya Naidu, Meenakshi Thakur, Venkatesh Rangrajan, Rajendra Kerkar, Sudeep Gupta, Shyam K. Shrivastava
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-15 (2018)
Standard guidelines for the management of early and locally advanced cervical cancer are available from various academic consortiums nationally and internationally. However, implementing standard-of-care treatment poses unique challenges within low-
Externí odkaz:
https://doaj.org/article/8060386cfa8447b6863c6606e71df0a2
Autor:
Govind Babu, A Goel, S Agarwal, S Gupta, P Kumar, B K Smruti, V Goel, R Sarangi, M Gairola, S Aggarwal, Purvish M Parikh
Publikováno v:
South Asian Journal of Cancer, Vol 7, Iss 2, Pp 123-126 (2018)
Breast cancer is a leading cause of death among women, and its incidence increases with age. Currently the treatment of breast cancer in older patients is almost identical to their younger counterparts. This expert group used data from published lite
Externí odkaz:
https://doaj.org/article/4a5e5d82a2e84c908f6bc7cc23ccd686
Autor:
Babu Suresh, Vikas Asati, K C Lakshmaiah, Govind Babu, D Lokanatha, Linu Abraham Jacob, K N Lokesh, A H Rudresh, L K Rajeev, Saldanha Smitha, Abhishek Anand, Rajesh Patidar, C S Premalata
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 57-59 (2019)
Background: Gastrointestinal tract (GIT) is the most common extranodal site for non-Hodgkin's lymphoma (NHL) and constitutes about 10%-15% of all NHL. This was a prospective study to evaluate the epidemiological, clinicopathological characteristics,
Externí odkaz:
https://doaj.org/article/c4be278554bc412ba9a1fe4735057953
Autor:
Govind Babu, Ankur Bahl, G S Bhattacharya, K T Bhowmik, P S Dattatraya, Nikhil Ghadyalpatil, S M Karandikar, Padmaj Kulkarni, Nithya Sridharan, Purvish Parikh, Kumar Prabhash, T Raja, S Rajasundaram, S Subramanian, Kaustav Talapatra, Ashok Vaid
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 4, Pp 154-160 (2017)
We present the 2017 Oncology Gold Standard Practical Consensus Recommendation for use of monoclonal antibodies in the management of advanced squamous cell carcinoma of head neck region.
Externí odkaz:
https://doaj.org/article/d1b8f7b728a8465887d2aaf76badce33
Autor:
A H Rudresha, Tamojit Chaudhuri, Kuntegowdanahalli C Lakshmaiah, Govind Babu, K N Lokesh, L K Rajeev
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 4, Pp 165-168 (2017)
Background: Primary central nervous system lymphoma (PCNSL) is a rare form of aggressive extranodal non-Hodgkin's lymphoma which occurs in both immunocompromised and immunocompetent patients. It has an overall poor prognosis in spite of a multimodali
Externí odkaz:
https://doaj.org/article/9c05740fe9bb46f798e33fbb4e6e4e9d
Autor:
Govind Babu, Umesh Das, Kuntejowdahalli Lakshmaiah, Lokanatha Dasappa, Linu Abraham Jacob, Suresh Babu
Publikováno v:
Journal of the Scientific Society, Vol 43, Iss 3, Pp 140-143 (2016)
Introduction: Aflibercept in combination with FOLFIRI has been shown to improve overall survival in the pivotal VELOUR study. Aflibercept has not yet been marketed in India. Sanofi has made available this drug for Indian patients under a program call
Externí odkaz:
https://doaj.org/article/2c1a53cf14a64024989cab1f1e12fa76
Autor:
Suresh Babu Mallekavu, Aditi Harsh Thanky, Govind Babu Kanakasetty, Lakshmaiah Kuntegowdanahalli, Lokanatha Dasappa, Linu A Jacob
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 4, Pp 151-153 (2017)
Context: Carcinoma cervix is a leading cause of cancer in Indian females where 15%–60% of the cases eventually metastasize. Bone only metastasis is rare, and data on its response and survival with systemic therapy as compared to other visceral meta
Externí odkaz:
https://doaj.org/article/f4ebb32a23ee442a84b3687f25b11c95